C
RCUS icon

Covestor’s Arcus Biosciences RCUS Stock Holding History

Covestor’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
7
– – ﹤0.01% 2683
2025
Q4 		$0 Hold
7
– – ﹤0.01% 2653
2025
Q3 		$0 Sell
7
-180
-96% -$1.87K ﹤0.01% 2674
2025
Q2 		$2K Buy
187
+63
+51% +$538 ﹤0.01% 1882
2025
Q1 		$1K Sell
124
-21
-14% -$243 ﹤0.01% 2077
2024
Q4 		$2K Buy
145
+138
+1,971% +$2.25K ﹤0.01% 1931
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2653
2024
Q2 		$0 Buy
7
+3
+75% +$48 ﹤0.01% 2654
2024
Q1 		$0 Sell
4
-1
-20% -$17 ﹤0.01% 2640
2023
Q4 		$0 Hold
5
– – ﹤0.01% 2604
2023
Q3 		$0 Sell
5
-1
-17% -$20 ﹤0.01% 2596
2023
Q2 		$0 Hold
6
– – ﹤0.01% 2545
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2471
2022
Q4 		$0 Sell
6
-3
-33% -$83 ﹤0.01% 2498
2022
Q3 		$0 Sell
9
-1
-10% -$26 ﹤0.01% 2473
2022
Q2 		$0 Sell
10
-3
-23% -$73 ﹤0.01% 2279
2022
Q1 		$0 Sell
13
-4
-24% -$134 ﹤0.01% 2380
2021
Q4 		$1K Buy
+17
New +$659 ﹤0.01% 1899

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Covestor's RCUS Position: Q1 2026 in Review

Covestor held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2683.

Covestor first reported a position in RCUS in Q4 2021 and has held it in 18 quarters since. The position peaked at $2K in Q2 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Covestor held 7 shares of Arcus Biosciences worth $0 as of Q1 2026.
  • Covestor left its Arcus Biosciences share count unchanged in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2683 holding.
  • Covestor first reported a position in Arcus Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Arcus Biosciences position peaked at $2K in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.